Michael-Robin Witt

Showing: 1 - 1 of 1 Articles

Gabather files two new patent applications to secure novel findings on the effects of GT-002 for the treatment of psychiatric disorders

Gabather AB (Nasdaq First North Growth Market: GABA) today reports that two new US provisional …